Effectiveness of weekly azathioprine pulse in the treatment of chronic plaque psoriasis: an open-label study: reply to author

Clinical and Experimental Dermatology ◽

10.1111/ced.13193 ◽

2017 ◽

Vol 42 (7) ◽

pp. 805-806

Author(s):

S. Sarika ◽

S. Criton

Keyword(s):

Plaque Psoriasis ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Download Full-text

Effectiveness of weekly azathioprine pulse in the treatment of chronic plaque psoriasis: an open-label study

Clinical and Experimental Dermatology ◽

10.1111/ced.12887 ◽

2016 ◽

Vol 41 (7) ◽

pp. 717-722 ◽

Author(s):

P. Verma ◽

K. K. Verma ◽

N. Khanna ◽

S. Gupta ◽

N. Bhari

Keyword(s):

Plaque Psoriasis ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Download Full-text

A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2014.07.048 ◽

2014 ◽

Vol 71 (6) ◽

pp. 1176-1182 ◽

Author(s):

Kenneth B. Gordon ◽

Craig L. Leonardi ◽

Mark Lebwohl ◽

Andrew Blauvelt ◽

Gregory S. Cameron ◽

...

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Interleukin 17A

Download Full-text

Long-term Safety and Efficacy of Roflumilast Cream 0.3% in Adult Patients With Chronic Plaque Psoriasis: Results From a 52-Week, Phase 2b Open-Label Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.5.supp.44 ◽

2021 ◽

Vol 5 (6) ◽

pp. s44

Author(s):

Linda Stein Gold ◽

Melinda Gooderham ◽

Kim Papp ◽

Laura Ferris ◽

Mark Lebwohl ◽

...

Keyword(s):

Plaque Psoriasis ◽

Adult Patients ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy

N/A

Download Full-text

An open-label study of alefacept plus ultraviolet B light as combination therapy for chronic plaque psoriasis

Journal of the European Academy of Dermatology and Venereology ◽

10.1111/j.1468-3083.2005.01247.x ◽

2005 ◽

Vol 19 (5) ◽

pp. 556-563 ◽

Author(s):

JP Ortonne ◽

A Khemis ◽

JYM Koo ◽

J Choi

Keyword(s):

Combination Therapy ◽

Plaque Psoriasis ◽

Ultraviolet B ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Download Full-text

Faculty Opinions recommendation of A 52-week, open-label study of the efficacy and safety of ixekizumab, an anti-interleukin-17A monoclonal antibody, in patients with chronic plaque psoriasis.

Faculty Opinions – Post-Publication Peer Review of the Biomedical Literature ◽

10.3410/f.718882523.793500240 ◽

2014 ◽

Author(s):

Luigi Naldi

Keyword(s):

Monoclonal Antibody ◽

Plaque Psoriasis ◽

Efficacy And Safety ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Interleukin 17A

Download Full-text

A multicenter, open‐label study of repeat courses of intramuscular alefacept in combination with other psoriasis therapies in patients with chronic plaque psoriasis

Journal of Dermatological Treatment ◽

10.1080/09546630701846103 ◽

2008 ◽

Vol 19 (3) ◽

pp. 146-155 ◽

Author(s):

Gerald G. Krueger ◽

Alice B. Gottlieb ◽

Wolfram Sterry ◽

Neil Korman ◽

Peter Van De Kerkhof

Keyword(s):

Plaque Psoriasis ◽

Chronic Plaque Psoriasis ◽

Open Label Study ◽

Download Full-text

25709 Halobetasol propionate lotion 0.05% in patients 12 to 16 years 11 months of age with plaque psoriasis: Results from an open label study evaluating adrenal suppression potential

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2021.06.291 ◽

2021 ◽

Vol 85 (3) ◽

pp. AB66

Author(s):

Vivian Laquer ◽

David Davidson ◽

Andrea Nguyen ◽

Tien Nguyen

Keyword(s):

Plaque Psoriasis ◽

Adrenal Suppression ◽

Open Label Study ◽

Download Full-text

A long-term, open-label study of the safety and efficacy of oral tazarotene in moderate to very severe plaque psoriasis

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2003.10.012 ◽

2004 ◽

Vol 50 (3) ◽

pp. P2 ◽

Author(s):

Alan Menter ◽

Deborah Lew-Kaya ◽

Frederick Beddingfield ◽

Patricia S. Walker

Keyword(s):

Plaque Psoriasis ◽

Open Label Study ◽

Label Study ◽

Safety And Efficacy ◽

Severe Plaque Psoriasis

Download Full-text

Safety and Tolerability of Fixed Combination Halobetasol Propionate 0.01% and Tazarotene 0.045% (HP/TAZ) Lotion in Patients With Moderate-to-Severe Plaque Psoriasis: Results From a 1-Year, Open-Label Study

SKIN The Journal of Cutaneous Medicine ◽

10.25251/skin.4.supp.38 ◽

2020 ◽

Vol 4 (5) ◽

pp. s38

Author(s):

Mark G Lebwohl ◽

Jeffrey Sugarman ◽

David M Pariser ◽

Jerry Bagel ◽

Cynthia Trickett ◽

...

Keyword(s):

Plaque Psoriasis ◽

Fixed Combination ◽

Open Label Study ◽

Label Study ◽

Severe Plaque Psoriasis

Abstract not available.

Download Full-text

Pharmacokinetics and safety of apremilast in pediatric patients with moderate to severe plaque psoriasis: Results from a phase 2 open-label study

Journal of the American Academy of Dermatology ◽

10.1016/j.jaad.2019.08.019 ◽

2020 ◽

Vol 82 (2) ◽

pp. 389-397 ◽

Author(s):

Amy S. Paller ◽

Ying Hong ◽

Emily M. Becker ◽

Raul de Lucas ◽

Maria Paris ◽

...

Keyword(s):

Plaque Psoriasis ◽

Pediatric Patients ◽

Phase 2 ◽

Open Label Study ◽

Label Study ◽

Severe Plaque Psoriasis

Download Full-text